Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Patient Records
2.3. Hospital Anxiety and Depression Scale
2.4. Cystic Fibrosis Questionnaire-Revised
2.5. Statistical Analyses
3. Results
3.1. Patient Characteristics
3.2. Quality of Life Scale
3.3. Predictors of HRQOL
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Elborn, J.S. Cystic Fibrosis. Lancet 2016, 388, 2519–2531. [Google Scholar] [CrossRef]
- Granados, A.; Chan, C.L.; Ode, K.L.; Moheet, A.; Moran, A.; Holl, R. Cystic Fibrosis Related Diabetes: Pathophysiology, Screening and Diagnosis. J. Cyst Fibros 2019, 18 (Suppl. 2), S3–S9. [Google Scholar] [CrossRef] [Green Version]
- Anabtawi, A.; Le, T.; Putman, M.; Tangpricha, V.; Bianchi, M.L. Cystic Fibrosis Bone Disease: Pathophysiology, Assessment and Prognostic Implications. J Cyst. Fibros. 2019, 18 (Suppl. 2), S48–S55. [Google Scholar] [CrossRef]
- Hughan, K.S.; Daley, T.; Rayas, M.S.; Kelly, A.; Roe, A. Female Reproductive Health in Cystic Fibrosis. J. Cyst. Fibros. 2019, 18 (Suppl. S2), S95–S104. [Google Scholar] [CrossRef] [Green Version]
- Guta, M.T.; Tekalign, T.; Awoke, N.; Fite, R.O.; Dendir, G.; Lenjebo, T.L. Global Burden of Anxiety and Depression among Cystic Fibrosis Patient: Systematic Review and Meta-Analysis. Int. J. Chronic Dis. 2021, 2021, 6708865. [Google Scholar] [CrossRef]
- Abbott, J.; Elborn, J.S.; Georgiopoulos, A.M.; Goldbeck, L.; Marshall, B.C.; Sabadosa, K.A.; Smith, B.A.; Quittner, A.L. Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of Cystic Fibrosis Mental Health Care Delivery. J. Cyst. Fibros. 2015, 14, 533–539. [Google Scholar] [CrossRef] [Green Version]
- Quittner, A.L.; Buu, A.; Messer, M.A.; Modi, A.C.; Watrous, M. Development and Validation of The Cystic Fibrosis Questionnaire in the United States: A Health-Related Quality-of-Life Measure for Cystic Fibrosis. Chest 2005, 128, 2347–2354. [Google Scholar] [CrossRef]
- Salek, M.S.; Jones, S.; Rezaie, M.; Davies, C.; Mills, R.; Ketchell, R.I. Do Patient-Reported Outcomes Have a Role in the Management of Patients with Cystic Fibrosis? Front. Pharmacol. 2012, 3, 38. [Google Scholar] [CrossRef] [Green Version]
- Ratnayake, I.; Ahern, S.; Ruseckaite, R. A Systematic Review of Patient-Reported Outcome Measures (PROMs) in Cystic Fibrosis. BMJ Open 2020, 10, e033867. [Google Scholar] [CrossRef]
- Kilcoyne, A.; Lavelle, L.P.; McCarthy, C.J.; McEvoy, S.H.; Fleming, H.; Gallagher, A.; Loeve, M.; Tiddens, H.; McKone, E.; Gallagher, C.C.; et al. Chest CT Abnormalities and Quality of Life: Relationship in Adult Cystic Fibrosis. Ann. Transl. Med. 2016, 4, 87. [Google Scholar] [CrossRef] [Green Version]
- Cheney, J.; Vidmar, S.; Gailer, N.; Wainwright, C.; Douglas, T.A. Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group Health-Related Quality-of-Life in Children with Cystic Fibrosis Aged 5-Years and Associations with Health Outcomes. J. Cyst. Fibros. 2020, 19, 483–491. [Google Scholar] [CrossRef] [Green Version]
- Quittner, A.L.; Modi, A.C.; Wainwright, C.; Otto, K.; Kirihara, J.; Montgomery, A.B. Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients with Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Airway Infection. Chest 2009, 135, 1610–1618. [Google Scholar] [CrossRef] [Green Version]
- Habib, A.-R.R.; Manji, J.; Wilcox, P.G.; Javer, A.R.; Buxton, J.A.; Quon, B.S. A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis. Ann. Am. Thorac. Soc. 2015, 12, 420–428. [Google Scholar] [CrossRef] [Green Version]
- Goetz, D.M.; Frederick, C.; Savant, A.; Cogswell, A.; Fries, L.; Roach, C.; Shea, N.; Borowitz, D.; Smith, B. Systematic Depression and Anxiety Screening for Patients and Caregivers: Implementation and Process Improvement in a Cystic Fibrosis Clinic. BMJ Open Qual. 2021, 10, e001333. [Google Scholar] [CrossRef]
- Yohannes, A.M.; Willgoss, T.G.; Fatoye, F.A.; Dip, M.D.; Webb, K. Relationship between Anxiety, Depression, and Quality of Life in Adult Patients with Cystic Fibrosis. Respir. Care 2012, 57, 550–556. [Google Scholar] [CrossRef] [Green Version]
- Havermans, T.; Colpaert, K.; Dupont, L.J. Quality of Life in Patients with Cystic Fibrosis: Association with Anxiety and Depression. J. Cyst. Fibros. 2008, 7, 581–584. [Google Scholar] [CrossRef] [Green Version]
- Cronly, J.A.; Duff, A.J.; Riekert, K.A.; Fitzgerald, A.P.; Perry, I.J.; Lehane, E.A.; Horgan, A.; Howe, B.A.; Ni Chroinin, M.; Savage, E. Health-Related Quality of Life in Adolescents and Adults With Cystic Fibrosis: Physical and Mental Health Predictors. Respir. Care 2019, 64, 406–415. [Google Scholar] [CrossRef] [Green Version]
- Kauser, S.; Keyte, R.; Regan, A.; Nash, E.F.; Fitch, G.; Mantzios, M.; Egan, H. Exploring Associations Between Self-Compassion, Self-Criticism, Mental Health, and Quality of Life in Adults with Cystic Fibrosis: Informing Future Interventions. J. Clin. Psychol. Med. Settings 2021, 29, 332–343. [Google Scholar] [CrossRef]
- Lian, R.; Cavalheri, V.; Wood, J.; Jenkins, S.; Straker, L.M.; Hill, K. Higher Levels of Education Are Associated With Full-Time Work in Adults With Cystic Fibrosis. Respir. Care 2019, 64, 1116–1122. [Google Scholar] [CrossRef]
- Borawska-Kowalczyk, U.; Bodnar, R.; Meszaros, A.; Sands, D. Comparison of Health-Related Quality of Life among Children with Cystic Fibrosis and Their Parents in Two Eastern European Countries. J. Cyst. Fibros. 2015, 14, 798–804. [Google Scholar] [CrossRef] [Green Version]
- Curran, M.; Tierney, A.C.; Button, B.; Collins, L.; Kennedy, L.; McDonnell, C.; Sheikhi, A.; Jurascheck, A.; Casserly, B.; Cahalan, R. Physical Activity and Sedentary Behavior in Adults With Cystic Fibrosis: Association With Aerobic Capacity, Lung Function, Sleep, Well-Being, and Quality of Life. Respir. Care 2021, 67, 339–346. [Google Scholar] [CrossRef]
- Leso, V.; Carnovale, V.; Iacotucci, P.; Pacella, D.; Romano, R.; Della Volpe, I.; Iavicoli, I. Employment Status and Work Ability in Adults with Cystic Fibrosis. Int. J. Environ. Res. Public Health 2021, 18, 11776. [Google Scholar] [CrossRef]
- Dury, S.; Perotin, J.-M.; Ravoninjatovo, B.; Llerena, C.; Ancel, J.; Mulette, P.; Griffon, M.; Carré, S.; Perrin, A.; Lebargy, F.; et al. Identifying Specific Needs in Adult Cystic Fibrosis Patients: A Pilot Study Using a Custom Questionnaire. BMC Pulm. Med. 2021, 21, 270. [Google Scholar] [CrossRef]
- Friedman, S.; Samuelian, J.C.; Lancrenon, S.; Even, C.; Chiarelli, P. Three-Dimensional Structure of the Hospital Anxiety and Depression Scale in a Large French Primary Care Population Suffering from Major Depression. Psychiatry Res. 2001, 104, 247–257. [Google Scholar] [CrossRef]
- Zigmond, A.S.; Snaith, R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983, 67, 361–370. [Google Scholar] [CrossRef] [Green Version]
- Modi, A.C.; Driscoll, K.A.; Montag-Leifling, K.; Acton, J.D. Screening for Symptoms of Depression and Anxiety in Adolescents and Young Adults with Cystic Fibrosis: Depression and Anxiety Symptoms in Patients With CF. Pediatr. Pulmonol. 2011, 46, 153–159. [Google Scholar] [CrossRef] [Green Version]
- Henry, B.; Aussage, P.; Grosskopf, C.; Goehrs, J.-M. Development of the Cystic Fibrosis Questionnaire (CFQ) for Assessing Quality of Life in Pediatric and Adult Patients. Qual. Life Res. 2003, 12, 63–76. [Google Scholar] [CrossRef]
- Baiardini, I.; Steinhilber, G.; DI Marco, F.; Braido, F.; Solidoro, P. Anxiety and Depression in Cystic Fibrosis. Minerva Med. 2015, 106, 1–8. [Google Scholar]
- Quittner, A.L.; Goldbeck, L.; Abbott, J.; Duff, A.; Lambrecht, P.; Solé, A.; Tibosch, M.M.; Bergsten Brucefors, A.; Yüksel, H.; Catastini, P.; et al. Prevalence of Depression and Anxiety in Patients with Cystic Fibrosis and Parent Caregivers: Results of The International Depression Epidemiological Study across Nine Countries. Thorax 2014, 69, 1090–1097. [Google Scholar] [CrossRef] [Green Version]
- Kimball, H.; Douglas, T.; Sanders, M.; Cobham, V.E. Anxiety in Children with Cystic Fibrosis and Their Parents: A Systematic Review. Clin. Child Fam. Psychol. Rev. 2021, 24, 370–390. [Google Scholar] [CrossRef]
- Forte, G.C.; Barni, G.C.; Perin, C.; Casarotto, F.C.; Fagondes, S.C.; de Dalcin, P.T.R. Relationship Between Clinical Variables and Health-Related Quality of Life in Young Adult Subjects With Cystic Fibrosis. Respir. Care 2015, 60, 1459–1468. [Google Scholar] [CrossRef] [Green Version]
- Abbott, J.; Hurley, M.A.; Morton, A.M.; Conway, S.P. Longitudinal Association between Lung Function and Health-Related Quality of Life in Cystic Fibrosis. Thorax 2013, 68, 149–154. [Google Scholar] [CrossRef] [Green Version]
- Künzi, L.; Easter, M.; Hirsch, M.J.; Krick, S. Cystic Fibrosis Lung Disease in the Aging Population. Front. Pharmacol. 2021, 12, 601438. [Google Scholar] [CrossRef]
- Quittner, A.L.; Sawicki, G.S.; McMullen, A.; Rasouliyan, L.; Pasta, D.J.; Yegin, A.; Konstan, M.W. Erratum to: Psychometric Evaluation of the Cystic Fibrosis Questionnaire-Revised in a National, US Sample. Qual. Life Res. 2012, 21, 1279–1290. [Google Scholar] [CrossRef] [Green Version]
- Bradley, J.M.; Blume, S.W.; Balp, M.-M.; Honeybourne, D.; Elborn, J.S. Quality of Life and Healthcare Utilisation in Cystic Fibrosis: A Multicentre Study. Eur. Respir. J. 2013, 41, 571–577. [Google Scholar] [CrossRef] [Green Version]
- Dill, E.J.; Dawson, R.; Sellers, D.E.; Robinson, W.M.; Sawicki, G.S. Longitudinal Trends in Health-Related Quality of Life in Adults with Cystic Fibrosis. Chest 2013, 144, 981–989. [Google Scholar] [CrossRef] [Green Version]
- Taylor-Robinson, D.; Schlüter, D.K.; Diggle, P.J.; Barrett, J.K. Explaining the Sex Effect on Survival in Cystic Fibrosis: A Joint Modeling Study of UK Registry Data. Epidemiology 2020, 31, 872–879. [Google Scholar] [CrossRef]
- Tomaszek, L.; Dębska, G.; Cepuch, G.; Kulpa, M.; Pawlik, L.; Broniatowska, E. Evaluation of Quality of Life Predictors in Adolescents and Young Adults with Cystic Fibrosis. Heart Lung 2019, 48, 159–165. [Google Scholar] [CrossRef]
- Targett, K.; Bourke, S.; Nash, E.; Murphy, E.; Ayres, J.; Devereux, G. Employment in Adults with Cystic Fibrosis. Occup. Med. 2014, 64, 87–94. [Google Scholar] [CrossRef] [Green Version]
- Havermans, T.; Colpaert, K.; Vanharen, L.; Dupont, L.J. Health Related Quality of Life in Cystic Fibrosis: To Work or Not to Work? J. Cyst. Fibros. 2009, 8, 218–223. [Google Scholar] [CrossRef] [Green Version]
- Demars, N.; Uluer, A.; Sawicki, G.S. Employment Experiences among Adolescents and Young Adults with Cystic Fibrosis. Disabil. Rehabil. 2011, 33, 922–926. [Google Scholar] [CrossRef]
- Daly, C.; Ruane, P.; O’Reilly, K.; Longworth, L.; Vega-Hernandez, G. Caregiver Burden in Cystic Fibrosis: A Systematic Literature Review. Ther. Adv. Respir. Dis. 2022, 16, 17534666221086416. [Google Scholar] [CrossRef]
- Delelis, G.; Christophe, V.; Leroy, S.; Vanneste, J.; Wallaert, B. The Effects of Cystic Fibrosis on Couples: Marital Satisfaction, Emotions, and Coping Strategies. Scand. J. Psychol. 2008, 49, 583–589. [Google Scholar] [CrossRef]
- Besier, T.; Schmitz, T.G.; Goldbeck, L. Life Satisfaction of Adolescents and Adults with Cystic Fibrosis: Impact of Partnership and Gender. J. Cyst. Fibros. 2009, 8, 104–109. [Google Scholar] [CrossRef] [Green Version]
- Williams, C.; Johnson, B.; Middleton, P.G.; Backer, V.; Gibson, P.G.; Hollis, G.; Coleman, C. Family Planning, Pregnancy and Birth in Women with Lung Conditions: A Worldwide Survey. ERJ Open Res. 2021, 7, 00357–02021. [Google Scholar] [CrossRef]
- Barker, H.; Moses, J.; O’Leary, C. “I’ve Got to Prioritise”: Being a Parent with Cystic Fibrosis. Psychol. Health Med. 2017, 22, 744–752. [Google Scholar] [CrossRef]
- Cammidge, S.L.; Duff, A.J.A.; Latchford, G.J.; Etherington, C. When Women with Cystic Fibrosis Become Mothers: Psychosocial Impact and Adjustments. Pulm. Med. 2016, 2016, 9458980. [Google Scholar] [CrossRef]
- Gulledge, A.; Miller, S.; Mueller, M. Social Support and Social Isolation in Adults with Cystic Fibrosis: An Integrative Review. J. Psychosom. Res. 2021, 150, 110607. [Google Scholar] [CrossRef]
- Kauser, S.; Keyte, R.; Mantzios, M.; Egan, H. A Qualitative Exploration into Experiences and Attitudes Regarding Psychosocial Challenges, Self-Compassion, and Mindfulness in a Population of Adults with Cystic Fibrosis. J. Clin. Psychol. Med. Settings 2022. [Google Scholar] [CrossRef]
- Sutharsan, S.; McKone, E.F.; Downey, D.G.; Duckers, J.; MacGregor, G.; Tullis, E.; Van Braeckel, E.; Wainwright, C.E.; Watson, D.; Ahluwalia, N.; et al. Efficacy and Safety of Elexacaftor plus Tezacaftor plus Ivacaftor versus Tezacaftor plus Ivacaftor in People with Cystic Fibrosis Homozygous for F508del-CFTR: A 24-Week, Multicentre, Randomised, Double-Blind, Active-Controlled, Phase 3b Trial. Lancet Respir. Med. 2022, 10, 267–277. [Google Scholar] [CrossRef]
- Martin, C.; Burnet, E.; Ronayette-Preira, A.; de Carli, P.; Martin, J.; Delmas, L.; Prieur, B.; Burgel, P.-R. Patient Perspectives Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease. Respir. Med. Res. 2021, 80, 100829. [Google Scholar] [CrossRef]
Variables | n = 50 |
---|---|
Male | 35 (70) |
Age, years | 25 (21–32) |
BMI, kg/m² | 21 (20–23) |
CFTR mutation | |
ΔF508 homozygous | 20 (40) |
ΔF508 heterozygous | 25 (50) |
Other | 5 (10) |
Pancreatic insufficiency | 40 (80) |
Diabetes | 17 (34) |
Exacerbation in the last year | 34 (68) |
Colonization | |
Pseudomonas aeruginosa | 18 (36) |
Staphylococcus aureus | 31 (62) |
FEV1, % predicted | 57 (37–90) |
HADS-Anxiety | 6 (3–8) |
HADS-Depression | 3 (1–6) |
Variables | n = 50 |
---|---|
Familial status | |
Partner | 33 (67) |
Living with their parents | 16 (33) |
Having children | 4 (8) |
Occupational status | |
Student/Professional training | 14 (29) |
Professional activity | 25 (51) |
Social dimension | |
Sport | 36 (74) |
Hobbies | 41 (84) |
Psychological follow-up | 6 (13) |
Social assistance | 23 (47) |
CFQ-R Domain | n = 50 |
---|---|
Physical functioning | 75 (54–92) |
Role perception | 83 (67–94) |
Vitality | 58 (42–75) |
Emotion | 80 (60–98) |
Social perception | 61 (51–67) |
Body image | 67 (56–83) |
Eating disturbance | 100 (89–100) |
Treatment burden | 67 (44–72) |
Health perception | 67 (44–72) |
Weight | 67 (33–100) |
Respiratory symptoms | 71 (62–76) |
Digestive symptoms | 89 (78–100) |
Regression Model Adjusted R² | ||||
---|---|---|---|---|
Dependent Variable | HADS Anxiety Component | HADS Depression Component | ||
CFQ-R Domains | % | p-Value | % | p-Value |
Physical functioning | 55.3 | <0.0001 | 65.2 | <0.0001 |
Role perception | 26.6 | 0.001 | 21.1 | 0.003 |
Vitality | 55.8 | <0.0001 | 65.5 | <0.0001 |
Emotion | 70.6 | <0.0001 | 61.4 | <0.0001 |
Social perception | 16.3 | 0.022 | 23.6 | 0.003 |
Body image | 46.6 | <0.0001 | 57.1 | <0.0001 |
Eating disturbance | 7.6 | ns | 7.6 | ns |
Treatment burden | 26.1 | 0.008 | 12.0 | 0.023 |
Health perception | 70.2 | <0.0001 | 64.0 | <0.0001 |
Weight | 31.9 | 0.003 | 31.9 | 0.003 |
Respiratory symptoms | 22.7 | 0.014 | 32.1 | 0.002 |
Digestive symptoms | 33.6 | 0.001 | 24.0 | 0.011 |
Dependent Variable | Independent Variable | Standardized Regression Coefficient | |
---|---|---|---|
CFQ-R Domains | Predictors | β | p-Value |
Physical functioning | |||
Age | −0.328 | 0.012 | |
Sex–Male | 0.500 | 0.000 | |
FEV1% | 0.262 | 0.032 | |
HADS anxiety | −0.338 | 0.005 | |
Sport | 0.211 | 0.068 | |
Role perception | |||
HADS anxiety | −0.516 | 0.001 | |
Vitality | |||
Age | −0.296 | 0.010 | |
Sex–Male | 0.373 | 0.002 | |
HADS anxiety | −0.479 | <0.0001 | |
Sport | 0.242 | 0.027 | |
Emotion | |||
Age | −0.266 | 0.009 | |
HADS anxiety | −0.737 | <0.0001 | |
Partner presence | 0.155 | 0.088 | |
Having children | −0.192 | 0.043 | |
Professional activity | 0.247 | 0.014 | |
Social perception | |||
Exacerbation (last year) | 0.248 | 0.086 | |
Social assistance | 0.356 | 0.015 | |
Body image | |||
BMI | 0.299 | 0.011 | |
HADS anxiety | −0.545 | <0.0001 | |
Hobbies | −0.217 | 0.059 | |
Treatment burden | |||
HADS anxiety | −0.343 | 0.021 | |
Having children | −0.272 | 0.072 | |
Professional activity | 0.369 | 0.014 | |
Health perception | |||
Age | −0.342 | 0.002 | |
FEV1% | 0.360 | 0.001 | |
Exacerbation (last year) | −0.202 | 0.034 | |
HADS anxiety | −0.480 | <0.0001 | |
Having children | −0.179 | 0.070 | |
Professional activity | 0.311 | 0.003 | |
Weight | |||
Sex–Male | −0.301 | 0.027 | |
BMI | 0.352 | 0.011 | |
Living with their parents | −0.298 | 0.033 | |
Psychological follow-up | 0.339 | 0.018 | |
Respiratory symptoms | |||
Exacerbation (last year) | −0.326 | 0.041 | |
HADS anxiety | −0.323 | 0.043 | |
Digestive symptoms | |||
HADS anxiety | −0.420 | 0.002 | |
Partner presence | −0.322 | 0.017 | |
Hobbies | −0.280 | 0.036 |
Dependent Variable | Independent Variable | Standardized Regression Coefficient | |
---|---|---|---|
CFQ-R Domains | Predictors | β | p-Value |
Physical functioning | |||
HADS depression | −0.505 | <0.0001 | |
Role perception | |||
HAD depression | −0.459 | 0.003 | |
Vitality | |||
Sex–Male | 0.358 | 0.001 | |
Exacerbation (last year) | −0.191 | 0.055 | |
HADS depression | −0.638 | <0.0001 | |
Living with their parents | −0.230 | 0.051 | |
Professional training | 0.337 | 0.007 | |
Emotion | |||
HADS depression | −0.707 | <0.0001 | |
Partner presence | 0.241 | 0.021 | |
Having children | −0.198 | 0.058 | |
Social assistance | −0.227 | 0.028 | |
Social perception | |||
HADS depression | −0.422 | 0.003 | |
Living with their parents | −0.277 | 0.044 | |
Body image | |||
BMI | 0.393 | 0.000 | |
HADS depression | −0.592 | <0.0001 | |
Social assistance | −0.252 | 0.018 | |
Treatment burden | |||
Professional activity | 0.346 | 0.023 | |
Health perception | |||
FEV1 % | 0.489 | <0.0001 | |
HADS depression | −0.633 | <0.0001 | |
Having children | −0.213 | 0.031 | |
Weight | |||
Sex–Male | −0.301 | 0.027 | |
BMI | 0.352 | 0.011 | |
Living with their parents | −0.298 | 0.033 | |
Psychological follow-up | 0.339 | 0.018 | |
Respiratory symptoms | |||
Exacerbation (last year) | −0.275 | 0.068 | |
HADS depression | −0.451 | 0.004 | |
Digestive symptoms | |||
HADS depression | −0.286 | 0.046 | |
Partner presence | −0.285 | 0.046 | |
Hobbies | −0.260 | 0.069 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ancel, J.; Launois, C.; Perotin, J.-M.; Ravoninjatovo, B.; Mulette, P.; Hagenburg, J.; Malet, J.; Griffon, M.; Carré, S.; Lebargy, F.; et al. Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthcare 2022, 10, 1351. https://doi.org/10.3390/healthcare10071351
Ancel J, Launois C, Perotin J-M, Ravoninjatovo B, Mulette P, Hagenburg J, Malet J, Griffon M, Carré S, Lebargy F, et al. Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthcare. 2022; 10(7):1351. https://doi.org/10.3390/healthcare10071351
Chicago/Turabian StyleAncel, Julien, Claire Launois, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Pauline Mulette, Jean Hagenburg, Julie Malet, Muriel Griffon, Sophie Carré, François Lebargy, and et al. 2022. "Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors" Healthcare 10, no. 7: 1351. https://doi.org/10.3390/healthcare10071351
APA StyleAncel, J., Launois, C., Perotin, J.-M., Ravoninjatovo, B., Mulette, P., Hagenburg, J., Malet, J., Griffon, M., Carré, S., Lebargy, F., Deslée, G., & Dury, S. (2022). Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthcare, 10(7), 1351. https://doi.org/10.3390/healthcare10071351